Advertisement
Advertisement

IXHL

IXHL logo

Incannex Healthcare Limited - ADR

1.60
USD
+0.01
+0.32%
Feb 21, 15:58 UTC -5
Closed
exchange

Pre-Market

1.62

+0.01
+0.62%

Incannex Healthcare Limited - ADR Profile

About

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

Info & Links

CEO

Joel Latham

Headquarters

Suite 105, 8 Century Circuit
Norwest, NSW 2153, AUSTRALIA

Industry

Medical Drugs

Sector

Medical

Website

www.incannex.com

Auditor

GRANT THORNTON AUDIT PTY LTD

Share holders

4,991

Employees

9

Incannex Healthcare Limited - ADR Statistics

Valuation Measures

Market Capitalization2

28.93M

Enterprise Value

30.60M

Enterprise Value/EBITDA(ttm)

-1.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

29.34

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-14110.25%

Return on Equity(ttm)

-289.30%

Return on Invested Capital(ttm)

-358.38%

Return on Assets(ttm)

-154.96%

Income Statement

Revenue(ttm)

86.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

86.00K

EBITDA(ttm)3

-28.17M

Net Income Available to Common(ttm)

-23.81M

Diluted EPS(ttm)

-1.39

Share Statistics

Beta (5Y Monthly)

7.44

52-Week Change

-66.35%

S&P 500 52-Week Change

18.61%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

17.86M

Dividend Yield

0.00%

Float4

13.12M

% Held by Insiders

26.53%

% Held by Institutions

0.43%

Balance Sheet

Total Cash(mrq)

2.10M

Total Cash Per Share(mrq)

0.12

Total Debt(mrq)

3.77M

Total Debt/Equity(mrq)

390.47%

Current Ratio(mrq)

1.80%

Quick Ratio(mrq)

1.65%

Book Value Per Share(mrq)

0.05

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.45

Free Cash Flow(ytd)

-7.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement